Biopharmaceutical Manufacturing: Midstream Processing - Harvest
Biopharmaceutical Manufacturing
Midstream Processing - Harvest
Overview
The midstream processing phase encompasses the harvest of cellular products during biopharmaceutical manufacturing.
It involves removing host cell material and solid impurities from the cultures after the protein production phase has concluded.
Techniques utilized in this phase also allow for some soluble impurity removal.
The process is designed to maintain bioburden control and incorporates clean-in-place and aseptic techniques.
Key Processes in Midstream Harvesting
Cell Harvest and Product Separation
Commences post-protein production phase.
Focuses on solid impurity removal alongside optional removal of some soluble impurities.
Essential aspects of the process include:
Bioburden control.
Clean-in-place methodologies.
Aseptic techniques.
Types of Filters Used
Liquid Filtration:
Sterilizing-grade pre-filters and filters.
Important for ensuring sterility in the final product.
Air Filtration:
Sterilizing-grade air filters and aerobic aeration.
Downstream Processing Techniques
Utilizes buffer filters, centrifuges, depth filtration, tangential flow filtration, and lenticulars for further purification.
Involves polishing steps and overall formulation and filling processes.
Critical Considerations in Harvesting
Process Stream Parameters
Cell Density.
Cell Viability.
Solids Load and Size.
Host Cell Proteins (HCP) and DNA Presence.
Product/process specificity in Cell Line (CHO cells):
Proteome: 6164 proteins.
Secretome: 1977 proteins.
Intracellular vs. Extracellular
Understanding whether proteins are intracellular or extracellular is crucial for choosing appropriate harvesting techniques.
Intracellular Proteins: Located within the cell.
Extracellular Proteins: Found in the extracellular space, especially significant for microbial and mammalian cells.
Techniques for Cell Disruption
Methods for Harvesting Intracellular Proteins
Mechanical Techniques:
Homogenization, lysis buffer, sonication, bead milling, freeze/thaw cycles.
Non-Mechanical Techniques:
Chemical methods (e.g., detergents): may lead to protein denaturation and impacts on purification processes.
Biological methods (e.g., enzymatic treatments).
Homogenization Process
High-pressure homogenization involves:
Forcing cell suspension through a small orifice at high pressure, generating high shear forces.
Flashing pressure allowing rupture of microbial cells.
Cooling systems are essential to prevent protein denaturation due to heat generated during the process.
Multiple passes through the homogenizer may improve cell breakage efficiency.
Bead Mill Agitation Method
Cells mixed with 0.2-0.3 mm glass beads and agitated vigorously.
The mechanical force from bead collisions disrupts the cells effectively, dependent on bead/cell ratio and agitation duration.
Industrial Scale Systems
Capable of processing over 1000 liters per hour, cooling systems mitigate heat damage.
Post-homogenization, centrifugation or filtration removes cellular debris.
Harvesting Extracellular Proteins (ECP)
Requirements and Techniques
No need for cell membrane or wall disruption.
Technologies include:
Centrifugation: Separates particles based on density differences, utilizing centrifugal force to segregate heavier particles (cells/debris) from lighter impurities/products.
Filtration Methods: Incorporate various filtration strategies like depth filtration, tangential flow filtration, etc.
Centrifugation Process Details
Principle of Operation
Particles of higher density than the solvent will sediment, while lighter particles float.
The efficiency depends on the density difference and cell characteristics.
Types of Centrifuges Used:
Rotatory Bowl Centrifuge: Implements rotation to separate materials.
Tubular Bowl Centrifuge: Features a distributor/baffle assembly for component separation.
Disc Stacked Centrifuge: Increases settling area, accommodates higher efficiency separation.
Separation Efficiency and Limitations
Can achieve up to 80% separation efficiency, although many factors affect overall effectiveness including:
Varied particle sizes and densities.
Increased viscosity from biological components.
Process scale limitations.
Heat generation impacting protein integrity.
Conclusion
Midstream harvesting in biopharmaceutical manufacturing is a complex interplay of mechanistic and biological strategies designed to recover proteins while minimizing degradation and contamination. It requires a meticulous balance between efficient solid impurity removal and maintaining the integrity of the desired biological products.